Science News & Analysis

FDA loses 3,500 employees; drug factory inspections compromised, safety labs shuttered (April 1, 2025)

April 1, 2025 — The Trump administration's mass layoff of 3,500 FDA employees — roughly 15 percent of the agency's entire workforce — on April 1 eliminated not just administrative staff but key scientists and inspection support personnel, in ways that directly threatened the safety of the nation's drug supply. Virtually all scientists in the FDA's San Juan, Puerto Rico and Detroit drug safety laboratories were cut, leaving only labs in a handful of other locations. Support staff who book international travel, secure translators, and coordinate logistics for the agency's 230 foreign drug inspectors were largely eliminated, creating immediate operational paralysis for overseas inspection programs.

This matters acutely because approximately 90 percent of the active pharmaceutical ingredients used in American medications are manufactured outside the United States — primarily in China and India — and the FDA's ability to inspect those facilities is the primary safeguard against unsafe or fraudulent products entering the U.S. drug supply. The agency had been struggling with inspector shortages even before the cuts: a Government Accountability Office analysis found that between 2021 and 2024, the vacancy rate among foreign and domestic facility investigators had already jumped from 9 to 16 percent, and about a third of existing inspectors lacked the experience to conduct independent foreign inspections. The mass layoffs set those numbers back further.

Within weeks, the FDA acknowledged partial reversals — about 24 of the nearly 200 cut inspection support staff were offered reinstatement, focused specifically on travel booking for foreign inspections. But multiple current inspectors told ProPublica that the ongoing strain of policing an industry spread across more than 90 countries had left staff exhausted and morale damaged, with experienced longtime investigators departing and less experienced personnel left to identify dangerous and sometimes deliberately deceptive manufacturing practices.